Resultado de búsqueda
Arvid Carlsson (Upsala, 25 de enero de 1923-Gotemburgo, 29 de junio de 2018) [1] fue un médico, neurocientífico, farmacólogo, farmacéutico y profesor universitario sueco. Se doctoró en medicina en la Universidad de Lund y desde 1959 hasta 1988 fue catedrático de farmacología de la Universidad de Gotemburgo , Suecia.
Arvid Carlsson (25 January 1923 – 29 June 2018) was a Swedish neuropharmacologist who is best known for his work with the neurotransmitter dopamine and its effects in Parkinson's disease. For his work on dopamine, Carlsson was awarded the Nobel Prize in Physiology or Medicine in 2000, together with Eric Kandel and Paul Greengard .
Born: 25 January 1923, Uppsala, Sweden. Died: 29 June 2018, Gothenburg, Sweden. Affiliation at the time of the award: Göteborg University, Gothenburg, Sweden. Prize motivation: “for their discoveries concerning signal transduction in the nervous system” Prize share: 1/3. Life.
25 de abr. de 2024 · Arvid Carlsson, Swedish pharmacologist who, along with Paul Greengard and Eric Kandel, was awarded the 2000 Nobel Prize for Physiology or Medicine for his research establishing dopamine as an important neurotransmitter in the brain. Carlsson’s work led to a treatment for Parkinson disease.
Arvid Carlsson is a Swedish neuropharmacologist who shared the Nobel Prize in Medicine in 2000 for his discoveries on dopamine receptors and signal transduction. Learn about his life, education, research and achievements in this biographical profile.
26 de oct. de 2018 · On 29 June 2018, neuropsychopharmacology and the American College of Neuropsychopharmacology (ACNP) lost one of its giants and true pioneers, Dr. Arvid Carlsson, MD, PhD, Swedish pharmacologist...
Arvid Carlsson. Farmacólogo sueco de reconocido prestigio internacional, por sus estudios sobre la enfermedad de Parkinson.
